Playing by protocol
Designing and maintaining a protocol is one of the most challenging aspects of any clinical trial. Sachin Jagdale analyses
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Novartis receives positive opinion from CHMP for Lucentis
Lucentis recommended for approval in EU to treat patients with visual impairment due to choroidal neovascularization secondary to…
Stem cell study could aid quest to combat range of diseases
To better understand and develop treatments for diseases such as multiple sclerosis, Parkinson’s disease and muscular degeneration…
Value-added OTCs on the radar
Pharmaceutical players are striving to add value to their OTC products in order to catch the consumer's attention and stand out…
‘The import tax anomalies faced by MD manufacturers, are tariff barriers erected against…
Ajay Pitre, Managing Director, Sushrut-Adler group shares his thoughts on the challenges facing the Indian medical device industry…
DoP calls for comments on soft loan scheme for mid-sized pharma cos
With a corpus fund of Rs 500 crores, the Pharmaceutical Technology Upgradation Assistance Scheme (PTUAS) aims to coax them to…
Cipla expands collaboration with Meda in allergic rhinitis segment
Will build further on the existing collaboration by granting global commercialisation rights to Meda for Dymista
Quest Life Sciences to tap US market
To register 10-15 products in the US market, expand its formulation facility in Chennai
Zydus pioneers Indias first NCE, introduces Lipaglyn
Will launch it in the Indian market by the end of third quarter
Sun Pharma announces US FDA approval for generic depo-testosterone injection
Is indicated for replacement therapy in males for conditions associated with symptoms of deficiency or absence of endogenous…